Drugging the cancer genome: new challenges of infrequent and combinatorial targets

Curr Opin Investig Drugs. 2007 Jun;8(6):445-6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Combinatorial Chemistry Techniques
  • Drug Design
  • Genome, Human
  • Humans
  • Mutation / genetics
  • Mutation / physiology
  • Neoplasms / genetics*
  • RNA Interference

Substances

  • Antineoplastic Agents